ZONARE Features ZS3 Ultrasound System with Multiple Pediatric Transducers at Annual PICC World Congress
ZONE Sonography® Technology Enables Superb Imaging and Contrast Enhanced Ultrasound Optimization for the Pediatric Critical Care Patient
Toronto, Canada (PRWEB) June 06, 2016
ZONARE, a leading developer of next generation ultrasound technology based in the Silicon Valley, is featuring its ZONE Sonography® Technology (ZST) and ZS3 ultrasound system at the eighth annual World Congress on Pediatric Intensive and Critical Care (PICC) meeting being held June 5 – 8, 2016 in Toronto. ZST, the foundation of all ZONARE ultrasound systems, has helped thousands of physicians over the past decade to improve diagnostics including multiple applications in pediatric critical care.
“We specifically developed many transducers designed to serve the imaging needs of the pediatric patient,” said Glen McLaughlin, PhD, president of ZONARE. “In addition, working with renowned clinicians globally, most of these pediatric-oriented transducers have been optimized for contrast enhanced ultrasound (CEUS). CEUS has become increasingly used throughout the world, offering significant diagnostic support for this patient population.”
ZST enables pioneering imaging developments such as Advanced Acoustic Acquisition™, a software acquisition technique that breaks with traditional line-by-line imaging and instead uses large zones to acquire 90 percent more echo data at speeds of up to 10 times faster than conventional systems. The results are crystal clear images with exceptional temporal accuracy bringing diagnostic confidence to all imaging challenges.
ZST also drives Dynamic Pixel Focusing™ where, automatically, every pixel is optimally focused in every frame, at every depth and every time. No other technology eliminates manual focal zones and reveals structural clarity from the skin line to depths of up to 40 centimeters (cm), whether the smallest of neonates or the largest of bariatric pediatric patients.
“Our transducers, such as the C10-3, L20-5, C9-3 and L14-5w, can be used throughout the pediatric body habitus,” said McLaughlin. “Combined with our next generation ZST and CEUS, liver and echo imaging are particularly suitable for pediatric intensive and critical care settings. We consider this to be a special application strength from ZONARE with much more under development in the months to come.”
ZONARE is solely dedicated to ultrasound excellence through its innovative, award-winning next generation technology which provides the platform for the company’s Living Technology designed to meet its customers evolving imaging needs. The patented design and Zone Sonography ™ Technology (ZST) architecture of the Z.One PRO and ZS3 platforms deliver high-end image quality and clinical versatility. ZONARE is now an independently run, wholly owned subsidiary of Mindray Medical International. For more information, visit http://www.zonare.com.
# # #
For the original version on PRWeb visit: http://www.prweb.com/releases/2016/06/prweb13458331.htm